Z, N., B, P., M, H., M, S., U, K., YY, H., . . . R, C. (2004). Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. Cancer chemotherapy and pharmacology, 53(5), 433. https://doi.org/10.1007/s00280-003-0756-z
Chicago Style (17th ed.) CitationZ, Nikolova, Peng B, Hubert M, Sieberling M, Keller U, Ho YY, Schran H, and Capdeville R. "Bioequivalence, Safety, and Tolerability of Imatinib Tablets Compared with Capsules." Cancer Chemotherapy and Pharmacology 53, no. 5 (2004): 433. https://doi.org/10.1007/s00280-003-0756-z.
MLA (9th ed.) CitationZ, Nikolova, et al. "Bioequivalence, Safety, and Tolerability of Imatinib Tablets Compared with Capsules." Cancer Chemotherapy and Pharmacology, vol. 53, no. 5, 2004, p. 433, https://doi.org/10.1007/s00280-003-0756-z.